Makabe Clinic

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Migraine2 trials

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Pfizer2 trials

Closed trials

• Completed

  Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)

  NCT05399485· Phase 3· Pfizer· Source

• Completed

  Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)

  NCT05399459· Phase 3· Pfizer· Source